Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
March 15, 2016
Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancer
C Dickhoff, M Dahele, M A Paul, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 2, 2001
Dosimetric consequences of tumor mobility in radiotherapy of stage I non-small cell lung cancer--an analysis of data generated using 'slow' CT scans
J R van Sörnsen de Koste, F J Lagerwaard, R H Schuchhard-Schipper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 1997
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks
S Senan, R Rampling, M A Graham, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 1, 2014
Trimodality therapy for stage IIIA non-small cell lung cancer: benchmarking multi-disciplinary team decision-making and function
C Dickhoff, K J Hartemink, P M van de Ven, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial
M A Graham, S Senan, H Robin, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
December 24, 2013
Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors
C G Vos, M Dahele, J R van Sörnsen de Koste, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 1997
Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate
P C Levendag, P I Schmitz, P P Jansen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 27, 2012
Defining target volumes for stereotactic ablative radiotherapy of early-stage lung tumours: a comparison of three-dimensional 18F-fluorodeoxyglucose positron emission tomography and four-dimensional computed tomography
G G Hanna, J R van Sörnsen de Koste, M R Dahele, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
June 14, 2008
[Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival]
B J Slotman, C Faivre-Finn, G W P M Kramer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx
P C Levendag, P I Schmitz, P P Jansen, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
Lung Cancer (Amsterdam, Netherlands)
|
March 15, 2016
Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancer
C Dickhoff, M Dahele, M A Paul, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 2, 2001
Dosimetric consequences of tumor mobility in radiotherapy of stage I non-small cell lung cancer--an analysis of data generated using 'slow' CT scans
J R van Sörnsen de Koste, F J Lagerwaard, R H Schuchhard-Schipper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 1997
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks
S Senan, R Rampling, M A Graham, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 1, 2014
Trimodality therapy for stage IIIA non-small cell lung cancer: benchmarking multi-disciplinary team decision-making and function
C Dickhoff, K J Hartemink, P M van de Ven, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial
M A Graham, S Senan, H Robin, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
December 24, 2013
Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors
C G Vos, M Dahele, J R van Sörnsen de Koste, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 1997
Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate
P C Levendag, P I Schmitz, P P Jansen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 27, 2012
Defining target volumes for stereotactic ablative radiotherapy of early-stage lung tumours: a comparison of three-dimensional 18F-fluorodeoxyglucose positron emission tomography and four-dimensional computed tomography
G G Hanna, J R van Sörnsen de Koste, M R Dahele, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
June 14, 2008
[Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival]
B J Slotman, C Faivre-Finn, G W P M Kramer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx
P C Levendag, P I Schmitz, P P Jansen, et al.
Page
of 10